287 related articles for article (PubMed ID: 24524817)
1. Clinical significance of the neutrophil-lymphocyte ratio in venous thromboembolism patients with lung cancer.
Go SI; Lee A; Lee US; Choi HJ; Kang MH; Kang JH; Jeon KN; Park MJ; Kim SH; Lee GW
Lung Cancer; 2014 Apr; 84(1):79-85. PubMed ID: 24524817
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil-Lymphocyte Ratio is a Predictor of Venous Thromboembolism in Gastric Cancer Patients.
Du P
Clin Lab; 2019 May; 65(5):. PubMed ID: 31115236
[TBL] [Abstract][Full Text] [Related]
3. Venous thromboembolism risk prediction in ambulatory cancer patients: clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio.
Ferroni P; Riondino S; Formica V; Cereda V; Tosetto L; La Farina F; Valente MG; Vergati M; Guadagni F; Roselli M
Int J Cancer; 2015 Mar; 136(5):1234-40. PubMed ID: 25042739
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil-Lymphocyte Ratio as a Predictor of Venous Thromboembolism after Total Knee Replacement.
Seo WW; Park MS; Kim SE; Lee JH; Park DG; Han KR; Oh DJ; Hyon MS
J Knee Surg; 2021 Jan; 34(2):171-177. PubMed ID: 31394586
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of the absolute monocyte counts in lung cancer patients with venous thromboembolism.
Go SI; Kim RB; Song HN; Kang MH; Lee US; Choi HJ; Jo W; Lee SJ; Cho YJ; Jeong YY; Kim HC; Lee JD; Kim SH; Kang JH; Lee GW
Tumour Biol; 2015 Sep; 36(10):7631-9. PubMed ID: 25921284
[TBL] [Abstract][Full Text] [Related]
6. [Neutrophil-to-lymphocyte ratio predicts the survival in patients with post-operative recurrence of non-small cell lung cancer].
Wang X; Li K
Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):298-302. PubMed ID: 24989918
[TBL] [Abstract][Full Text] [Related]
7. Venous thromboembolism in patients with cholangiocarcinoma: focus on risk factors and impact on survival.
Jeon HK; Kim DU; Baek DH; Ha DW; Lee BE; Ryu DY; Cheong JH; Kim GH; Song GA; Jang AL
Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):444-9. PubMed ID: 22410715
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and clinical significance of incidental and clinically suspected venous thromboembolism in lung cancer patients.
Connolly GC; Menapace L; Safadjou S; Francis CW; Khorana AA
Clin Lung Cancer; 2013 Nov; 14(6):713-8. PubMed ID: 23891560
[TBL] [Abstract][Full Text] [Related]
9. Venous Thromboembolism Is an Independent Predictor of Mortality Among Patients with Gastric Cancer.
Fuentes HE; Oramas DM; Paz LH; Wang Y; Andrade XA; Tafur AJ
J Gastrointest Cancer; 2018 Dec; 49(4):415-421. PubMed ID: 28634671
[TBL] [Abstract][Full Text] [Related]
10. Venous thromboembolism and nonsmall cell lung cancer: a pooled analysis of National Cancer Institute of Canada Clinical Trials Group trials.
Hicks LK; Cheung MC; Ding K; Hasan B; Seymour L; Le Maître A; Leighl NB; Shepherd FA
Cancer; 2009 Dec; 115(23):5516-25. PubMed ID: 19711465
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy.
Yao Y; Yuan D; Liu H; Gu X; Song Y
Cancer Immunol Immunother; 2013 Mar; 62(3):471-9. PubMed ID: 22986452
[TBL] [Abstract][Full Text] [Related]
12. The role of the nonspecific inflammatory markers in determining the anatomic extent of venous thromboembolism.
Bakirci EM; Topcu S; Kalkan K; Tanboga IH; Borekci A; Sevimli S; Acikel M
Clin Appl Thromb Hemost; 2015 Mar; 21(2):181-5. PubMed ID: 23814171
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil:lymphocyte ratio as a simple and novel biomarker for prediction of locoregional recurrence after chemoradiotherapy for squamous cell carcinoma of the anus.
Toh E; Wilson J; Sebag-Montefiore D; Botterill I
Colorectal Dis; 2014 Mar; 16(3):O90-7. PubMed ID: 24148256
[TBL] [Abstract][Full Text] [Related]
14. Preoperative plasma D-dimer levels predict survival in patients with operable non-small cell lung cancer independently of venous thromboembolism.
Zhang PP; Sun JW; Wang XY; Liu XM; Li K
Eur J Surg Oncol; 2013 Sep; 39(9):951-6. PubMed ID: 23810331
[TBL] [Abstract][Full Text] [Related]
15. Platelet-lymphocyte ratio is a predictor of venous thromboembolism in cancer patients.
Yang W; Liu Y
Thromb Res; 2015 Aug; 136(2):212-5. PubMed ID: 25533129
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of preoperative neutrophil-lymphocyte vs platelet-lymphocyte ratio in primary operable patients with non-small cell lung cancer.
Zhang H; Xia H; Zhang L; Zhang B; Yue D; Wang C
Am J Surg; 2015 Sep; 210(3):526-35. PubMed ID: 26105800
[TBL] [Abstract][Full Text] [Related]
17. [Significance of preoperative neutrophil-to-lymphocyte ratio as a predictor of prognosis in patients with stage IV colorectal cancer].
Shibutani M; Maeda K; Nagahara H; Noda E; Ohtani H; Sugano K; Takii M; Kimura K; Toyokawa T; Amano R; Kubo N; Tanaka H; Muguruma K; Ohira M; Hirakawa K
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1603-5. PubMed ID: 24393862
[TBL] [Abstract][Full Text] [Related]
18. The incidence, risk factors, and prognosis of recurrent venous thromboembolism (VTE) in patients with advanced solid cancers receiving anticoagulation therapy after the diagnosis of index VTE.
Yhim HY; Jang MJ; Kwak JY; Yim CY; Choi WI; Lee YC; Lee JO; Lee KW; Bang SM; Kim SH; Kim YK; Chang HJ; Oh D;
Thromb Res; 2013 Apr; 131(4):e133-40. PubMed ID: 23399441
[TBL] [Abstract][Full Text] [Related]
19. Clinical analysis of postoperative venous thromboembolism risk factors in lung cancer patients.
Yang Y; Zhou Z; Niu XM; Li ZM; Chen ZW; Jian H; Ai XH; Cheng BJ; Liao ML; Lu S
J Surg Oncol; 2012 Nov; 106(6):736-41. PubMed ID: 22711667
[TBL] [Abstract][Full Text] [Related]
20. Elevated preoperative inflammatory markers based on neutrophil-to-lymphocyte ratio and C-reactive protein predict poor survival in resected non-small cell lung cancer.
Tomita M; Shimizu T; Ayabe T; Nakamura K; Onitsuka T
Anticancer Res; 2012 Aug; 32(8):3535-8. PubMed ID: 22843942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
